Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1388.80
5.80 (0.42%) Cipla’s arm gets one observation for Goa facility
Date: 21-01-2025United States Food and Drugs Administration (USFDA) has conducted an inspection at the manufacturing facility of Medispray Laboratories, wholly owned subsidiary of Cipla, located in Kundaim, Goa from January 14 - 20, 2025.
On conclusion of the inspection, Medispray received 1 observation in Form 483. The company will work closely with the USFDA and remains committed to address these observations comprehensively within stipulated time.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.